These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7274047)

  • 21. Development of a vaginal suppository suitable for single administration for interruption of second trimester pregnancy.
    Bygdeman M; Ganguli A; Kinoshita K; Lundström V; Green K; Bergström S
    Contraception; 1977 Feb; 15(2):129-41. PubMed ID: 837687
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study.
    Smith SK; Baird DT
    Br J Obstet Gynaecol; 1980 Aug; 87(8):712-7. PubMed ID: 7426533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal contraceptives still evolving.
    Pearson RM
    Netw Res Triangle Park N C; 1986; 7(2):6. PubMed ID: 12340621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encare Oval: a clinical study.
    Barwin BN
    Contracept Deliv Syst; 1983 Sep; 4(4):331-4. PubMed ID: 12265811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaginal contraception with gossypol: a clinical study.
    Ratsula K; Haukkamaa M; Wichmann K; Luukkainen T
    Contraception; 1983 Jun; 27(6):571-6. PubMed ID: 6684533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of vaginal prostaglandin-E2 suppositories in septic abortion.
    Milano CT; Gleicher N
    Prostaglandins; 1980 Mar; 19(3):455-6. PubMed ID: 7384552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
    Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal contraceptives merge old forms, new data.
    Contracept Technol Update; 1983 Jul; 4(7):73-5. PubMed ID: 12339358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Properties of a new, long-lasting vaginal delivery system (LASRS) for contraceptive and antimicrobial agents.
    Zaneveld LJ; Waller DP; Ahmad N; Quigg J; Kaminski J; Nikurs A; De Jonge C
    J Androl; 2001; 22(3):481-90. PubMed ID: 11330649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaginal contraceptives: worldwide use remains low but methods have potential.
    Netw Res Triangle Park N C; 1986; 7(2):1, 5. PubMed ID: 12340618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaginal contraception--an update.
    Edelman DA; Thompson S
    Contracept Deliv Syst; 1982 Apr; 3(2):75-81. PubMed ID: 12338173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal spermicides and congenital disorders.
    JAMA; 1981 Dec; 246(23):2677-8. PubMed ID: 7310957
    [No Abstract]   [Full Text] [Related]  

  • 33. Termination of early pregnancy by ONO-802 suppositories (16,16-dimethyl-trans-delta2-PGE1 methyl ester).
    Takagi S; Sakata H; Yoshida T; Den K; Fujii TK; Amemiya H; Tomita M
    Prostaglandins; 1978 May; 15(5):913-9. PubMed ID: 704915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acceptability of two spermicides in five countries.
    Raymond E; Alvarado G; Ledesma L; Diaz S; Bassol S; Morales E; Fernandez V; Carlos G
    Contraception; 1999 Jul; 60(1):45-50. PubMed ID: 10549452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
    Wagatsuma T; Tabuchi T; Tabei T; Kaku R
    Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barrier contraceptive use and HIV infection among high-risk women in Cameroon.
    Zekeng L; Feldblum PJ; Oliver RM; Kaptue L
    AIDS; 1993 May; 7(5):725-31. PubMed ID: 8391273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effectiveness of barrier methods of contraception with and without spermicide.
    Craig S; Hepburn S
    Contraception; 1982 Oct; 26(4):347-59. PubMed ID: 6759027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal spermicides and gonorrhea.
    Jick H; Hannan MT; Stergachis A; Heidrich F; Perera DR; Rothman KJ
    JAMA; 1982 Oct; 248(13):1619-21. PubMed ID: 6809970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview of properties of Amphora (Acidform) contraceptive vaginal gel.
    Nelson AL
    Expert Opin Drug Saf; 2018 Sep; 17(9):935-943. PubMed ID: 30136907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spermicides for family planning and disease protection: an update.
    Townsend S
    Netw Res Triangle Park N C; 1991 Dec; 12(3):23-6. PubMed ID: 12284758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.